Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Recommendation of “Moderate Buy” by Analysts

by · The Cerbat Gem

Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the fifteen analysts that are covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation, twelve have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $24.86.

Several analysts have recently issued reports on PRVA shares. Evercore ISI lowered their price target on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Royal Bank of Canada reissued an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a research report on Wednesday, August 14th. Finally, Robert W. Baird boosted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 26th.

Check Out Our Latest Stock Analysis on PRVA

Insider Activity at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of the company’s stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the sale, the chief executive officer now owns 247,771 shares of the company’s stock, valued at $4,583,763.50. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 14.20% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Norges Bank bought a new position in Privia Health Group during the 4th quarter worth about $27,959,000. BlackBarn Capital Partners LP bought a new position in Privia Health Group during the 4th quarter worth about $3,109,000. Avenir Corp grew its holdings in Privia Health Group by 24.0% during the 4th quarter. Avenir Corp now owns 36,745 shares of the company’s stock worth $846,000 after acquiring an additional 7,100 shares in the last quarter. Vanguard Group Inc. grew its holdings in Privia Health Group by 2.5% during the 4th quarter. Vanguard Group Inc. now owns 11,278,334 shares of the company’s stock worth $259,740,000 after acquiring an additional 274,345 shares in the last quarter. Finally, Guidance Capital Inc. bought a new position in Privia Health Group during the 1st quarter worth about $388,000. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Stock Performance

Privia Health Group stock opened at $17.59 on Monday. Privia Health Group has a fifty-two week low of $15.92 and a fifty-two week high of $24.35. The stock has a market cap of $2.10 billion, a PE ratio of 117.27, a price-to-earnings-growth ratio of 4.22 and a beta of 0.76. The firm’s 50-day simple moving average is $19.29 and its 200 day simple moving average is $18.47.

Privia Health Group (NASDAQ:PRVA – Get Free Report) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.05 by ($0.02). The company had revenue of $422.30 million during the quarter, compared to the consensus estimate of $411.50 million. Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The business’s revenue was up 2.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.06 EPS. As a group, analysts predict that Privia Health Group will post 0.16 EPS for the current fiscal year.

Privia Health Group Company Profile

(Get Free Report

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Articles